- Home
- EVAX vs SSKN Comparison
EVAX vs SSKN Comparison
Compare EVAX & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- SSKN
- Stock Information
- Founded
- EVAX 2008
- SSKN 1989
- Country
- EVAX Denmark
- SSKN United States
- Employees
- EVAX N/A
- SSKN N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- SSKN Medical/Dental Instruments
- Sector
- EVAX Health Care
- SSKN Health Care
- Exchange
- EVAX Nasdaq
- SSKN Nasdaq
- Market Cap
- EVAX 10.8M
- SSKN 12.1M
- IPO Year
- EVAX 2021
- SSKN 2005
- Fundamental
- Price
- EVAX $3.13
- SSKN $2.43
- Analyst Decision
- EVAX Strong Buy
- SSKN Strong Buy
- Analyst Count
- EVAX 2
- SSKN 1
- Target Price
- EVAX $10.00
- SSKN $6.00
- AVG Volume (30 Days)
- EVAX 134.8K
- SSKN 11.9K
- Earning Date
- EVAX 05-27-2025
- SSKN 05-14-2025
- Dividend Yield
- EVAX N/A
- SSKN N/A
- EPS Growth
- EVAX N/A
- SSKN N/A
- EPS
- EVAX N/A
- SSKN N/A
- Revenue
- EVAX $3,293,000.00
- SSKN $33,620,000.00
- Revenue This Year
- EVAX N/A
- SSKN $3.31
- Revenue Next Year
- EVAX N/A
- SSKN $9.67
- P/E Ratio
- EVAX N/A
- SSKN N/A
- Revenue Growth
- EVAX 2555.64
- SSKN 3.30
- 52 Week Low
- EVAX $1.20
- SSKN $2.10
- 52 Week High
- EVAX $19.95
- SSKN $3.88
- Technical
- Relative Strength Index (RSI)
- EVAX 75.25
- SSKN 45.85
- Support Level
- EVAX $2.58
- SSKN $2.29
- Resistance Level
- EVAX $2.84
- SSKN $2.62
- Average True Range (ATR)
- EVAX 0.25
- SSKN 0.23
- MACD
- EVAX 0.10
- SSKN -0.02
- Stochastic Oscillator
- EVAX 96.79
- SSKN 22.06
About EVAX Evaxion Biotech
Evaxion AS is in the field of oncology. It used the AI-Immunology platform.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.